 Receptor, Angiotensin, Type 1
"Receptor, Angiotensin, Type 1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An angiotensin receptor subtype that is expressed at high levels in a variety of adult tissues including the CARDIOVASCULAR SYSTEM, the KIDNEY, the ENDOCRINE SYSTEM and the NERVOUS SYSTEM. Activation of the type 1 angiotensin receptor causes VASOCONSTRICTION and sodium retention.
| Descriptor ID |
D044140
|
| MeSH Number(s) |
D12.776.543.750.695.047.625 D12.776.543.750.750.130.750
|
| Concept/Terms |
Receptor, Angiotensin, Type 1- Receptor, Angiotensin, Type 1
- Angiotensin II Type 1 Receptor
- Angiotensin AT1 Receptor
- AT1 Receptor, Angiotensin
- Receptor, Angiotensin AT1
- Angiotensin Type 1 Receptor
- Receptor, Angiotensin II Type 1
Receptor, Angiotensin, Type 1b- Receptor, Angiotensin, Type 1b
- Angiotensin II Type 1b Receptor
- Angiotensin Type 1b Receptor
- Angiotensin AT1b Receptor
- AT1b Receptor, Angiotensin
- Receptor, Angiotensin AT1b
- Receptor, Angiotensin II Type 1b
Receptor, Angiotensin, Type 1a- Receptor, Angiotensin, Type 1a
- Angiotensin II Type 1a Receptor
- Angiotensin AT1a Receptor
- AT1a Receptor, Angiotensin
- Receptor, Angiotensin AT1a
- Angiotensin Type 1a Receptor
- Receptor, Angiotensin II Type 1a
|
Below are MeSH descriptors whose meaning is more general than "Receptor, Angiotensin, Type 1".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, G-Protein-Coupled [D12.776.543.750.695]
- Receptors, Angiotensin [D12.776.543.750.695.047]
- Receptor, Angiotensin, Type 1 [D12.776.543.750.695.047.625]
- Receptors, Peptide [D12.776.543.750.750]
- Receptors, Angiotensin [D12.776.543.750.750.130]
- Receptor, Angiotensin, Type 1 [D12.776.543.750.750.130.750]
Below are MeSH descriptors whose meaning is more specific than "Receptor, Angiotensin, Type 1".
This graph shows the total number of publications written about "Receptor, Angiotensin, Type 1" by people in this website by year, and whether "Receptor, Angiotensin, Type 1" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 | | 1998 | 0 | 1 | 1 | | 2001 | 0 | 1 | 1 | | 2003 | 0 | 1 | 1 | | 2005 | 0 | 1 | 1 | | 2006 | 0 | 1 | 1 | | 2007 | 0 | 2 | 2 | | 2008 | 0 | 1 | 1 | | 2012 | 0 | 1 | 1 | | 2014 | 1 | 0 | 1 | | 2020 | 1 | 0 | 1 | | 2022 | 1 | 1 | 2 | | 2023 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Receptor, Angiotensin, Type 1" by people in Profiles.
-
Figueroa MAC, Lujambio IM, Guti?rrez TA, Hern?ndez MFP, Ram?rez EYE, Guzm?n DJ, S?nchez MFL, Morales HFG, Samudio HJG, S?nchez FS, Flores MD, Zamarripa CAJ, Mendoza CCC, Hern?ndez MEO, Vel?zquez CMO, Flores MS, Orozco DVH, Moreno GYC, Cruz M, de Jes?s Peralta Romero J. Association of the rs5186 polymorphism of the AGTR1 gene with decreased eGFR in patients with type 2 diabetes from Mexico City. Nefrologia (Engl Ed). 2023 Sep-Oct; 43(5):546-561.
-
Self WH, Shotwell MS, Gibbs KW, de Wit M, Files DC, Harkins M, Hudock KM, Merck LH, Moskowitz A, Apodaca KD, Barksdale A, Safdar B, Javaheri A, Sturek JM, Schrager H, Iovine N, Tiffany B, Douglas IS, Levitt J, Busse LW, Ginde AA, Brown SM, Hager DN, Boyle K, Duggal A, Khan A, Lanspa M, Chen P, Puskarich M, Vonderhaar D, Venkateshaiah L, Gentile N, Rosenberg Y, Troendle J, Bistran-Hall AJ, DeClercq J, Lavieri R, Joly MM, Orr M, Pulley J, Rice TW, Schildcrout JS, Semler MW, Wang L, Bernard GR, Collins SP. Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19: Two Randomized Clinical Trials. JAMA. 2023 04 11; 329(14):1170-1182.
-
Moreno JD, Verma AK, Kopecky BJ, Dehner C, Kostelecky N, Vader JM, Lin CY, Schilling JD. Angiotensin II Type 1 Receptor Antibody-mediated Rejection Following Orthotopic Heart Transplant: A Single-center Experience. Transplantation. 2022 02 01; 106(2):373-380.
-
Marcum ZA, Cohen JB, Zhang C, Derington CG, Greene TH, Ghazi L, Herrick JS, King JB, Cheung AK, Bryan N, Supiano MA, Sonnen JA, Weintraub WS, Williamson J, Pajewski NM, Bress AP. Association of Antihypertensives That Stimulate vs Inhibit Types 2 and 4 Angiotensin II Receptors With Cognitive Impairment. JAMA Netw Open. 2022 01 04; 5(1):e2145319.
-
Deminice R, Hyatt H, Yoshihara T, Ozdemir M, Nguyen B, Levine S, Powers S. Human and Rodent Skeletal Muscles Express Angiotensin II Type 1 Receptors. Cells. 2020 07 14; 9(7).
-
Li W, Liu J, Hammond SL, Tjalkens RB, Saifudeen Z, Feng Y. Angiotensin II regulates brain (pro)renin receptor expression through activation of cAMP response element-binding protein. Am J Physiol Regul Integr Comp Physiol. 2015 Jul 15; 309(2):R138-47.
-
Sutliff RL, Walp ER, Kim YH, Walker LA, El-Ali AM, Ma J, Bonsall R, Ramosevac S, Eaton DC, Verlander JW, Hansen L, Gleason RL, Pham TD, Hong S, Pech V, Wall SM. Contractile force is enhanced in Aortas from pendrin null mice due to stimulation of angiotensin II-dependent signaling. PLoS One. 2014; 9(8):e105101.
-
Kim S, Toyokawa H, Yamao J, Satoi S, Yanagimoto H, Yamamoto T, Hirooka S, Yamaki S, Inoue K, Matsui Y, Kwon AH. Antitumor effect of angiotensin II type 1 receptor blocker losartan for orthotopic rat pancreatic adenocarcinoma. Pancreas. 2014 Aug; 43(6):886-90.
-
Chicco AJ, Brown DA. "Roid-Rage" at the cellular level: abolition of endogenous cardioprotection by anabolic steroids reveals new links between the RAAS and cardiac KATP channels : editorial to: "AT1 and aldosterone receptors blockade prevents the chronic effect of nandrolone on the exercise-induced cardioprotection in perfused rat heart subjected to ischemia and reperfusion" by S.R. Marques-Neto et al. Cardiovasc Drugs Ther. 2014 Apr; 28(2):113-4.
-
Mahishi LH, Hart RP, Lynch DR, Ratan RR. miR-886-3p levels are elevated in Friedreich ataxia. J Neurosci. 2012 Jul 04; 32(27):9369-73.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|